[Skip to Navigation]
Views 441
Citations 0
Comment & Response
April 23, 2020

Obesity Paradox in Patients With Non–Small Cell Lung Cancer Treated With Immunotherapy—Reply

Author Affiliations
  • 1Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia
  • 2Department of Medical Oncology, Flinders Centre for Innovation in Cancer, Flinders Medical Centre/Flinders University, Bedford Park, South Australia
JAMA Oncol. 2020;6(6):941-942. doi:10.1001/jamaoncol.2020.0643

In Reply We thank Sanchez and Furberg for their thoughtful comments in response to our recent article in JAMA Oncology on the association between body mass index (BMI) and overall survival with immune checkpoint inhibitor therapy for patients with advanced non–small cell lung cancer.1 We agree that the association of body size with survival outcomes in patients with advanced cancer is complex and evolving.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words